Prevention of cigarette smoke induced lung cancer by low LET ionizing radiation

Nuclear Engineering and Technology

Volumn 40, Issue 7, 2008, Pages 539-550

  Sanders, Charles L ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Cigarette smoke; Lung cancer; Radiation hormesis

Indexed keywords

EID: 58149269190     PISSN: 17385733     EISSN: None     Source Type: Journal    
DOI: 10.5516/NET.2008.40.7.539     Document Type: Article

References (182)

1. Jernal A, A Thomas, T Murray and M Thun. Cancer statistics. CA Cancer J Clin 52:23-47 (2002).
2. Chyou PH, AM Nomura and GN Stemmermann. A prospective study of the attributable risk of cancer due to cigarette smoking. Amer. J. Public Health 82:37-40 (1992).
3. Field AW, D Krewski, JH Lubin, et al. An overview of the North American residential radon and lung cancer case-control studies. J Toxicol Environ Hlth Part A 69:599-631 (2006).
4. National Research Council. Committee on Health Risks of Exposure to Radon, "Health Effects of Exposure to Radon" (BEIR VI), National Academy Press, Washington, DC (1999).
5. U.S. Enviromnental Protection Agency (EPA). "Air toxics risk assessment reference library". Volume 1, Technical Resource Manual, Office of Air Quality Planning Standards, Emissions Standards Division (2004).
6. Sanders CL. Hormesis as a Confounding Factor in Epidemiological Studies of Radiation Carcinogenesis. Korean Assoc Radiat Prot 31:69-89 (2006).
7. Aurengo A, D Averbeck, A Bonnin, et al. "Dose-Effect Relationships and Estimation of the Carcinogenic Effects of Low Doses of Ionizing Radiation". Executive Summary. French Academy of Sciences, French National Academy of Medicine (2005).
8. Tubiana M and A Aurengo. 2005. Dose-Effect Relationship and Estimation of the Carcinogenic Effect of Low Doses of Ionizing Radiation. Int J Low Radiation 2:134-151 (2005).
9. Leonard BE. Adaptive response and human benefit: Part I. A microdosimetry dose-dependent model. Intern J Radiat Biol 83:115-131 (2007).
10. Luckey TD. Radiation Hormesis. CRC Press, Boca Raton, FL (1991).
11. Luckey TD. A Rosetta stone for ionizing radiation. ROS Magazine 8:22-30 (2003).
12. Tubiana M, A Aurengo, D Averbeck, et al. "Dose-effect relationships and the estimation of the carcinogenic effects of low doses of ionizing radiation". Joint Report of the French National Academies of Science and of Medicine, Edition Nucleon, Paris (2005).
13. Tubiana M, A Aurengo, D Averbeck, et al. The debate on the use of linear no threshold for assessing the effects of low doses. J Radiol Prot 26:317-324 (2006).
14. Mitchel REJ, NJ Gragtmans and DP Morrison. Beta-radiation-induced resistance to MNNG initiation of papilloma but not carcinoma formation in mouse skin. Radiat Res 121:180-186 (1999).
15. Monchaux G, JP Mother, M Morin, et al. Carcinogenic and cocarcinogenesis effects of radon and radon daughters in rats. Environ Health Perspect 102:64-73 (1994).
16. Sakai K, Y Hoshi, T Nomura T, et al. Suppression of carcinogenic processes in mice by chronic low dose rat gamma-irradiation. Int J Low Radiat 1: 142-146 (2003).
17. Sanders CL and BR Scott. Smoking and Hormesis as Confounding Factors in Radiation Pulmonary Carcinogenesis. Dose-Response 6:53-79 (2008).
18. Thompson HJ, R Strange and PJ Schedin. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol Biomarkers Prev 1:597-602 (1992).
19. Stephens LC, K Kang, TE Schultheiss, et al. Apoptosis in irradiated murine tumors. Radiat Res 127:308-316 (1991).
20. Thomas DC, KG McNeill and C Dougherty. Estimates of lifetime lung-cancer risks resulting from Rn progeny exposures. Health Phys 49:825-846 (1985).
21. Thompson RE, DF Nelson, JH Popkin and Z Popkin. Case-control study of lung cancer risk from residential radon exposure in Worcester County, Massachusetts. Health Phys 94:228-241 (2008).
22. Scott BF, SA Belinsky, S Leng, et al. Radiation-stimulated epigenetic reprogramming of adaptive-response genes in the lung-an evolutionary gift for mounting adaptive protection against lung cancer. (submitted for publication) (2008).
23. Sanders CL. Prevention and Therapy of Cancer and Other Common Diseases: Alternative and Traditional Approaches. Infomedix, Richland, WA, 3000 pp (1996).
24. Blot WJ. Alcohol and cancer. Cancer Res. (suppl) 52:2119s-2123s (1992).
25. Hammond EC, IJ Selikoff and H Seidman. Asbestos exposure, cigarette smoking and death rates. Ann. NY Acad. Sci. 330:473-491 (1979).
26. Deetjen P and A Falkenbach (eds). "Radon und Gesundheit", P. Land, Frankfurt, Germany (1999)
27. Kreienbrock L, M Kreuzer, M Gerken, et al. Case-control study on lung cancer and residential radon in western Germany. Am J Epidemiol 153:42-52 (2001).
28. Wichmann H-E, A Schaffrath Rosario, IM Heid, et al. Increased lung cancer risk due to residential radon in a pooled and extended analysis of studies in Germany. Health Phys 88:71-79 (2005).
29. Crispo A, P Brennan, KH Jockel, et al. The cumulative risk of lung cancer among current, ex- and never-smokers in European men. Br J Cancer 91:1280-1286 (2004).
30. U.S. Public Health Service. "The health consequences of smoking: Cancer". A report of the Surgeon General. U. S. Publich Health Service, DHHS Publication no. (PHS) 82-50179 (1982).
31. Higson DJ, DR Boreham, AL Brooks and Y-C Luan. Effects of low doses of radiation: Joint statement from the following participants at the 15th Pacific Basin Nuclear Conference, October 2006. Dose-Response 5:259-262 (2007).
32. Sethi T. Science, medicine, and the future: lung cancer. Brit. J. Med. 314:652-660 (1997).
33. Rossi HH and M Zaider. Radiogenic lung cancer: The effects of low doses of low linear energy transfer (LET) radiation. Radiat. Environ. Biophys. 36:85-88 (1997).
34. Hornung RW and TJ Meinhardt. Quantitative risk assessment of lung cancer in U. S. uranium miners. Health Phys. 52:417-430 (1987).
35. Enflo A. Lung cancer risks from residential radon among smokers and non-smokers. J Radiol Prot 22:A95-A99) (2002).
36. Gustavsson P, R Jakobsson, F Nyberg, et al. Occupational exposure and lung cancer risk: a population-based case-referent study in Sweden. Am J Epidemiol 152:32-40 (2000).
37. IARC (International Agency for Research on Cancer). "Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42". (IARC monographs on the evaluation of carcinogenic risks to humans, supplement no. 7). Lyon, France: IARC, pp. 1-440 (1987).
38. Toth E, I Lazar, D Selmeczi, et. al. Lower cancer risk in medium high radon. Pathol. Oncol. Res. 4:125-9 (1998).
39. Villeneuve PJ, HI Morrison and R Lane. Radon and lung cancer risk: an extension of the mortality follow-up of the Newfoundland fluorspar cohort. Health Phys 92:157-169 (2007).
40. Doll R. The lessons of life: keynote address to the nutrition and cancer conference. Cancer Res 52:2024s-2029s (1992).
41. Darby S, D Hill, A Auvinen, et al. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies. Br Med J 330:223-228 (2005).
42. Lubin JH and JD Boice. Lung cancer risk from residential radon: meta-analysis of eight epidemiological studies. J Natl Cancer Inst 89:49-57 (1997).
43. Lubin JH, ZY Wang, JD Boice, et al. Risk of lung cancer and residential radon in China: Pooled results of two studies. Int J Cancer 109:132-137 (2004).
44. Neuberger JS. and TF Gesell. Residential radon exposure and lung cancer: Risk in nonsmokers. Health Phys 83:1-18 (2002).
45. Neuberger JS and RW Field. Occupation and lung cancer in nonsmokers. Rev Environ Health 18:251-267 (2003).
46. Schull WJ and KM Weiss. Radiation carcinogenesis in humans. Adv Radiat Biol 16:215-258 (1992).
47. Pierce DA, GB Sharp and K Mabuchi. Joint effects of radiation and smoking on lung cancer risk among atomic bomb survivors. Radiat. Res. 159:511-520 (2003).
48. Pierce DA, Y Shimizu, DL Preston, et al. Studies of the mortality of atomic bomb survivors. Report 12. 1. Cancer: 1950-1990. Radiat. Res. 146:1-27 (1996).
49. Kopecky KJ, E Nakashima, T Yamamoto, et al. Lung cancer, radiation, and smoking among A-bomb survivors, Hiroshima and Nagasaki: TR-13-86. Radiation Effects Research Foundation, Hiroshima (1986).
50. Little MP. Comparisons of lung tumour mortality risk in the Japanese A-bomb survivors and in the Colorado Plateau uranium miners: Support for the ICRP lung model. Intern. J. Radiat. Biol. 78:145-163 (2002).
51. Heidenreich WF, EG Luebeck, WD Hazelton, et al. Mutlistage Models and the Incidence of Cancer in the Cohort of Atomic Bomb Survivors. Radiat. Res. 158:607-614 (2002).
52. Gilbert ES, NA Koshurnikova, ME Sokolnikov, et al. Lung cancer in Mayak workers. Radiat. Res. 162:505-516 (2004).
53. Kreisheimer M, NA Koshurnikova, E Nekolla, et al. Lung Cancer Mortality Among Mate Nuclear Workers of the Mayak Facilities in the Former Soviet Union. Radiat. Res. 154:3-11 (2000).
54. Shilnikova NS, DL Preston, E Ron, et al. Cancer mortality risk among workers at the Mayak nuclear complex. Radiat. Res. 159:787-798 (2003).
55. Cardis E, M Vrijheid, M Blettner, et al. Risk of cancer after low doses of ionizing radiation: Retrospective cohort study in 15 countries. Brit. Med. J. 331:77-80 (2005).
56. Baverstock K and D Williams. Chernobyl: An overlooked aspect? Letters, Science 299:44 (2002).
57. Chernobyl Forum (IAEA, WHO, UNDP, UNEP, UNOCHA, UNSCEAR, World Bank). "Chernobyl's Legacy: Health, Environmental and Socio-Economic Impacts". The work is in three volumes and 600 pages by more than 100 scientists (2005).
58. Hatch M, E Ron, A Bouville, et al. The Chernobyl disaster: Cancer following the accident at the Chernobyl nuclear power plant. Epidemiol. Reviews 27:56-66 (2005).
59. Thompson, R.C. and Mahaffey, J.A. "Life-Span Radiation Effects Studies in Animals: What Can They Tell Us?" Proceedings of the 22nd Hanford Life Science Symposium, Richland, WA (1986).
60. Stannard, JN. "Radioactivity and Health: A History". Baalman RW (editor), Pacific Northwest Laboratory, Richland, WA (1988).
61. Gregoire O and MR Cleland. Novel approach to analyzing the carcinogenic effect of ionizing radiations. Int J Radiat Biol 82:13-19 (2006).
62. Okamoto K. Critical values of linear energy transfer, dose rates and doses for radiation hormesis. Health Phys 52:671-674 (1987).
63. Taylor LS. Some non-scientific influences on radiation protection standards and practice. Health Phys 32:851-874 (1980).
64. Cameron JR. Correspondence: Radiation increased the longevity of British radiologists. Br J Radiol 75:637-639 (2002).
65. Keirim-Markus IB. Radiation exposure normalization taking account of specific effects at low doses and dose rates. Atomic Energy 93:836-844 (2004).
66. Berrington A, SC Darby, HA Weiss, et al. 100 years of observation on British radiologists: mortality from cancer and other causes 1987-1997. Br J Radiol 74:507-519 (2001).
67. Atkinson WD, DV Law, KJ Bromley, et al. Mortality of employees of the United Kingdom Atomic Energy Authority, 1946-97. Occup Environ Med 61:577-585 (2004).
68. Ivanov V, L Iiyin, A Gorski, et al. Radiation and epidemiological analysis for solid cancer incidence among nuclear workers who participated in recovery operations following the accident at the Chernobyl NPP. J Radiat Res (Tokyo) 45:41-44 (2004).
69. Carpenter LM, V Beral and PG Smith. Cancer mortality in relation to monitoring for radionuclide exposure in three UK nuclear industry workforces. Br J Cancer 78:1224-1232 (1998).
70. McGeoghegan D and K Binks. The mortality and cancer morbidity experience of employees at the Chapelcross plant of British Nuclear Fuels, 1955-95. J Radiol Prot 21:221-250 (2001).
71. Zablotska LB, JP Ashmore and GR Howe. Analysis of mortality among Canadian nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat. Res. 161:633-641 (2004).
72. Sont WN, JM Zielinski, AP Ashmore, et al. First analysis of cancer incidence and occupational radiation exposure based on the National Dose Registry of Canada. Amer. J. Epidemiol. 153:309-318 (2001).
73. Iwasaki T, M Murata, S Ohshima, et al. Second analysis of nuclear industry workers in Japan, 1986-1997. Radiat. Res. 159:228-238 (2003).
74. Howe GR, LB Zablotska, JJ Fix, et al. Analysis of the mortality experience amongst U.S. nuclear power industry workers after chronic low-dose exposure to ionizing radiation. Radiat. Res. 162:517-526 (2004).
75. Wilkinson GS, N Trieff, R Graham, et al. "Final Report. Study of Mortality Among Female Nuclear Weapons Workers". Grant Numbers: 1R01 OHO3274, R01/CCR214546, R01/CCR61 2934-01, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (2000).
76. Matanoski GM. "Health effects of low-level radiation in shipyard workers. Final Report". Report No. DOE DEAC02-79EV10095. US Department of Energy, Washington, D.C (1991).
77. Yoshinaga S, T Aoyama, Y Yoshimotot, et al. Cancer mortality among radiological technologists in Japan: updated analysis of follow-up data from 1969 to 1993. J. Epidemiol. 9:61-72 (1999).
78. Doody MM, JS Mandel, JH Lubin, et al. Mortality among USA radiologic technologists 1926-1990. Cancer Causes Control 9:67-75 (1998).
79. Howe GR. Lung Cancer Mortality Between 1950 and 1987 after Exposure to Fractionated Moderate-Dose-Rate Ionizing Radiation in the Canadian Fluoroscopy Cohort Study and a Comparison with Lung Cancer Mortality in the Atomic Bomb Survivors Study. Radiat. Res. 142:295-304 (1995).
80. 1 Davis FG, JD Boice, C Hrubec, et. al. Lung cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 49:6130-6136 (1989).
81. Luxin WEI, T Sugahara and Z Tao. High level of natural radiation 1966: Radiation dose and health effects". Amsterdam, Elsevier (1997).
82. Calabrese EJ. Historical blunders: How toxicology got the dose-response relationship half right. Cell Molec Biol 51:643-654 (2005).
83. Howe GR, AM Chiarelli and JP Lindsay. Components and modifiers of the healthy worker effect: evidence from three occupational cohorts and implications for industrial compensation. Am J Epidemiol 128:1364-1375 (1988).
84. Franks P, MR Gol and CM Clancy. Use of care and subsequent mortality: the importance of gender. Health Serv Res 31:347-363 (1996).
85. Friedman GD, MF Collen and BH Fireman. Multiphasic health checkup evaluation: a 16-year follow-up. J Chronic Dis 39:453-463 (1986).
86. Chen WL, YC Luan, MC Shieh, et al. Is chronic radiation an effective prophylaxis against cancer? J. Amer. Physicians and Surgeons 9:6-10 (2004).
87. Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation. 2007. "Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII-Phase 2". National Academies Press, Washington, D.C (2007).
88. Monson RR. "Occupational Epidemiology". CRC Press, Boca Raton, FL (1990).
89. Vrijheid M, E Cardis, M Blettner, et al. The 15-country collaborative study of cancer risk among radiation workers in the nuclear industry: design, epidemiological methods and descriptive results. Radiat Res 167:361-379 (2007).
90. Spousler R and JR Cameron. Nuclear shipyard worker study (1980-1988): A large cohort exposed to low-dose-rate gamma radiation. Int. J. Low Radiation 1:463-478 (2005).
91. Skelcher B. Healthy worker effect. J Radiol Prot 21:71-72 (2001).
92. Rogel A, N Carre, E Amoros, et al. Mortality of workers exposed to ionizing radiation at the French National Electricity Company. Am J Indust Med 47:72-82 (2005).
93. Gros H, A Chevalier, et al. Epidemiological surveillance at Electricite de France-Gaz de France: health assessment of nuclear power plant employees between 1993 and 1998. Occup Med 52:35-44 (2002).
94. Hammer GP, F Fehringer, et al. Exposure and mortality in a cohort of German nuclear power workers. Radiat Environ Biophys 47:95-99 (2008).
95. Acquavella JF, LD Wiggs, RJ Waxweiter, et al. Mortality among workers at the Pantex weapons facility. Health Phys 48:735-746 (1985).
96. McGeoghegan D and K Binks. The mortality and cancer morbidity experience of workers at the Springfields uranium production facility, 1946-95. J Radiol Prot 20:111-137 (2000).
97. McGeoghegan D and K Binks. The mortality and cancer morbidity experience of workers at the Capenhurst uranium enrichment facility 1946-95. J Radiol Prot 20:381-401 (2000).
98. Gilbert ES, E Omohundro, JA Buchanan, et al. Mortality of workers at the Hanford site: 1945-1986. Health Phys 64:577-590 (1993).
99. Boice JD, SS Cohen, MT Mumma, et al. Mortality among radiation workers at Rocketdyne (Atomics International), 1948-1999. Radiat Res 166:98-115 (2006).
100. Schubauer-Berigan MK, GV Macievic, DF Utterback, et al. "An epidemiologic study of mortality and radiation-related risk among workers at the Idaho Engineering and Enviromnental Laboratory", a U.S. Department of energy facility. HHS (NIOSH) Publication No. 2005-131, Cincinnati, OH (2005).
101. Tokarskaya ZB, ND Okladnikova, ZD Belyaeva, et al. Multifactorial analysis of lung cancer dose-response relationships for workers at the Mayak nuclear enterprise. Health Phys 73:899-905 (1997).
102. Ivanov VK, AI Gorski, MA Maksioutov, et al. Mortality among the Chernobyl emergency workers: estimation of radiation risks (preliminary analysis). Health Phys 81:514-521 (2001).
103. Daunt N. Decreased cancer mortality of British radiologists. Br J Radiol 75:639 (2002).
104. Smith PG and R Doll. Mortality from cancer and all causes among British radiologists. Brit. J Radiol. 54:187-194 (1981).
105. Clouvas A, S Xanthos and M Antonopoulos-Domis. Simultaneous measurements of indoor radon, radon-thoron progeny and high-resolution gamma spectrometry in Greek dwellings. Radiat Pro Dosim. 118:482-490 (2006).
106. Mitsunobu F, K Yamaoka, K Hanamoto, et al. Elevation of antioxidant enzymes in the clinical effects of radon and thermal therapy for bronchial asduna. J. Radiat. Res. (Tokyo) 44:95-99 (2003).
107. Yamaoka K, C Sugie, S Futatsugawa, et al. Basic Study of Biologic Effects of Thoron Hot Spring on Hypertension. Proceedings of the Forty-Eighth Annual Meeting of the Japan Radiation Research Society/ the First Asian Congress of Radiation Research, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan, Abstract P-A-108, p. 139 (2005).
108. Takahashi M and S Kojima. Suppression of atopic dermatitis and tumor metastasis in mice by small amounts of radon. Radiat. Res. 165:337-342 (2006).
109. Franke A, L Reiner, Pratzel, et. al. Long-term efficacy of radon spa therapy in rheumatoid arthritis - a randomized, sham-controlled study and follow-up. Rheumatology 39: 894-902 (2000).
110. Bogoljubov WM. Clinical aspects of radon therapy in the USSR. Z. Phys. Med. Balneol. Med. Klimatol. 17:58-63 (1988).
111. Jagger J. Natural background radiation and cancer death in Rocky Mountain states and Gulf Coast states. Health Phys 75:428-430 (1998).
112. City of Fort Collins, CO. Air Quality Department, http:// www.ci.fort-collins.co.us/airqulaity/radon-health (2005).
113. National Council on Radiation Protection and Measurements. "Evaluation of the Linear-Nonthreshold Model for Ionizing Radiation". NCRP Report 136, Bethesda, MD: National Council on Radiation Protection and Measurements, p. 6 (2001).
114. Frigerio NA and RS Stowe. "Carcinogenic and genetic hazards from background radiation" (Vol. 2), pp. 385-393, IAEA, Vienna (1976).
115. Nambi, KSV and SD Soman. Environmental radiation and cancer in India. Health Phys 52:653-657 (1987).
116. Sun Q, ZS Akiba, Z Tao, et al. Excess risk of solid cancer mortality after prolonged exposure to naturally occurring high background radiation in Yangjiang, China. J Radiat Res (Tokyo) 41:43-52 (2000).
117. Tao T, Y Zha, S Akiba, et al. Cancer mortality in the high background radiation areas of Yangjiang, China during the period between 1979 and 1995. J Radiat Res (Tokyo) 41:31-41 (2000).
118. Wei L and T Sugahara. An introductory overview of the epidemiological study on the population at the high background radiation areas in Yangjiang, China. J Radiat Res (Toyko) 41:1-7 (2000).
119. Neuberger JS. Residential radon exposure and lung cancer: an overview of ongoing studies. Health Phys 63:503-509 (1992).
120. Wang Z, JH Lubin, L Wang, et al. Residential radon and lung cancer risk in a high-exposure area of Gansu Province, China. Am J Epidemiol 155:554-564 (2002).
121. Bowie C and SHU Bowie. Radon and health. Lancet 337:409-413 (1991).
122. Cohen BL. Test of the linear no-threshold theory of radiation carcinogenesis for inhaled radon decay products. Health Phys 68:157-174 (1995).
123. Cohen BL. A test of the linear no-threshold theory of radiation carcinogenesis. Environ Res 53:193-220 (1990).
124. Cohen BL. Radon exposure and the risk of lung cancer. J Radiat Prot 21:64-66 (2001).
125. Puskin JS. Smoking as a confounder in ecologic correlations of cancer mortality rates with average county radon levels. Health Phys 84:526-532 (2003).
126. Stidley CA. and JM Samet. A review of ecologic studies of lung cancer and indoor radon. Health Phys 65:234-251 (1993).
127. Cohen BL. Response to "residential radon exposures and lung cancer risk: Commentary on Cohen's county-based study". Health Phys 87:656-658 (2004).
128. Cohen BL. Updates and extensions to tests of the linear no-threshold theory. Technology 7:657-672 (2000).
129. Heath CW, PD Bond, DG Hoel and CB Meinhold. Residential radon exposure and lung cancer risk: Commentary on Cohen's county-based study. Health Phys 87:647-655 (2004).
130. Auvenin A, I Maekelaeinen, M Hakama, et al. Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland. J Natl Cancer Inst 88:966-972 (1996).
131. Haynes RM. The distribution of domestic radon concentrations and lung cancer mortality in England and Wales. Radiat Prot Dosim 25:93-96 (1988).
132. Lubin JH. Invited commentary: lung cancer and exposure to residential radon. Am J Epidemiol 140:323-332 (1994).
133. NCRP (National Council on Radiation Protection and Measurements). "Exposure of the population in the United States and Canada from natural background radiation". NCRP Report No. 94, Bethesda, MD (1987).
134. Lubin JH., JD Boice, C Edling, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst 87:817-827 (1995).
135. Lachet B. 2005. Indoor radon and lung cancer. Letters to the Editor. Epidemiol 17:121.
136. Cothern CR. Indoor air radon. Environ Geochem Health 21:83-90 (1999).
137. Lin CY, A Gelman, PN Price, et al. Analysis of local decisions using hierarchial modeling, applied to home radon radon measurement and remediation. Statistical Science 14:305-337 (1999).
138. Price P. "Assessing uncertainties in die relationship between inhaled particle concentrations, internal deposition, and health effects". In: Ruzer, LS (editor), Aerosol Handbook: Measurement, Dosimetry and Health Effects, pp. 157-188. CRC-Taylor & Francis (2004).
139. Lubin JH, L Tomasek, C Edling, et al. Estimating lung cancer mortality from residential radon using data for low exposures of miners. Radiat Res 147:126-134 (1997).
140. Krewski D, SN Rai, JM Zielinski, et al. Characterization of uncertainty and variability in residential radon cancer risks. Ann. N.Y. Acad Sci. 895:245-272 (1999).
141. Krewski D, JH Lubin, JM Zielinski, et al. Residential radon and risk of lung cancer. A combined analysis of 7 North American case-control studies. Epidemiol 16:137-145 (2005).
142. Pavia M, A Bianco, C Pileggi and Angelillo, I.F. Meta-analysis of residential exposure to radon gas and lung cancer. Bull World Health Organization 81:732-738 (2003).
143. Tracy BL, D Krewski, J Chen, et al. Assessment and management of residential radon health risks: a report from the Health Canada radon workshop. J Toxicol Environ Health A 69:735-758 (2006).
144. Kauffman JM. Radiation hormesis: Demonstrated, deconstructed, denied, dismissed, and some implications for public policy. J. Scientific Exploration 17:389-407 (2003).
145. Yarmoshenko I, I Kirdin and Zhukovsky, M. Uncertainty analysis of relative biological effectiveness of alpha-radiation for human lung exposure. J Toxicol Environmen Hlth Part A 69:665-679 (2006).
146. Ioannidis JP, AB Haidich and J Lau. Any casualties in the clash of randomized and observational evidence? Brit Med J 322:879-880 (2001).
147. Ioannidis JP. Why most published research findings are false. PLOS Medicine 2(8): (http://medicine.plosjournals.org/ perlserv?request=getdocument&doi=10.1371/journal.pm) (2005).
148. Vandenbroucke JP. When are observational studies as credible as randomized trials? Lancet 363:1728-1731 (2004).
149. Taubes G. Epidemiology faces its limits. Science 269:164-169 (1995).
150. Cavallo A, A Hutter and P Shebel. Radon progeny unattached fraction in an atmosphere far from radioactive equilibrium. Health Phys 76:532-536 (1999).
151. James AC, A Birchall and GH Akabani. Comparative dosimetry of BEIR VI revisited. Radiat Prot Dosim 108:3-26 (2002).
152. Puskin JS and AC James. Radon exposure assessment and dosimetry applied to epidemiology and risk estimation. Radiat Res 166:193-208 (2006).
153. Bruske-Hohfeld I, AS Rosario, G Wolke, et al. Lung cancer risk among former uranium miners of the Wismut Company in Germany. Health Phys 90:208-216 (2006).
154. Duport P. (2002). Is the radon risk overestimated? Neglected doses in the estimation of the risk of lung cancer in uranium underground miners. Radiat Prot Dosim 98:329-338 (2002).
155. Gilliland FD, WC Hunt, VE Archer, et al. Radon progeny exposure and lung cancer risk among non-smoking uranium miners. Health Phys 79:365-372 (2000).
156. Roscoe RJ, K Steenland and WE Halperin. Lung cancer mortality among nonsmoking uranium miners exposed to radon daughters. J Am Med Assoc 262:629-633 (1989).
157. Saccomano G, C Yale, W Dixon, et al. An epidemiological analysis of the relationship between exposure to Rn progeny, smoking and bronchogenic carcinoma in the U-mining population of the Colorado plateau- 1960-1980. Health Phys 50:605-618 (1986).
158. Woodward A, D Roder, AJ McMichael, et al. Radon daughter exposures at the Radium Hill uranium mine and lung cancer rates among former workers, 1952-87 Cancer Causes Control 2:213-220 (1991).
159. Xiang-Zhen X, JH Lubin, L Jun-Yao, et al. A cohort study in southern China of tin miners exposed to radon and radon decay products. Health Phys 64:120-131 (1993).
160. Darby SC, E Whitley, GR Howe, et al. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J Natl Cancer Inst 87:378-384 (1995).
161. Brown SC, MF Schonbeck, D McClure, et al. Lung cancer and internal lung doses among plutonium workers at the Rocky Flats plant: a case-control study. Am J Epidemiol 160:163-172 (2004).
162. Koshurnikova NA, MG Bolotnikova, LA Iyin, et al. Lung cancer risk due to exposure to incorporated plutonium. Radiat Res 149:366-371 (1998).
163. Rowlands RE, AF Stheney and HF Lucas. Dose-response relationships for radium-induced bone sarcomas. Health Phys 44(S1):15-31 (1983).
164. Andersson M. and HH Strom. Cancer incidence among Danish thorotrast patients. J Natl Cancer Inst 4:1318-1325 (1992).
165. Van Kaick G, H Wesch, H Luhrs, et al. Neoplastic diseases induced by chronic alpha irradiation. Epidemiological, biophysical and clinical results by the German Thoratrast study. J Radiat Res 32:20-33 (1991).
166. Tokarskaya ZB, GV Zhuntova,, BR Scott, et al. Influence of alpha and gamma radiations and non-radiation risk factors on the incidence of malignant liver tumors among Mayak workers. Health Phys 91:296-310 (2006).
167. Khokhriakov VF and SA Romanov. Estimation of the temporal distribution and dose dependency of lung cancer among workers of nuclear fuel reprocessing plant. Health Phys. 71:83-85 (1996).
168. Khokryakov V and S Romanov. Lung cancer in radiochemical industry workers. The Science of the Total Environment 142:25-28 (1994).
169. Tokarskaya ZB, BR Scott, GV Zhuntova, et al. Interaction of radiation and smoking in lung cancer induction among workers at the Mayak nuclear enterprise. Health Phys 83:833-846 (2002).
170. Voetz GL, JNP Lawrence and ER Johnson. Fifty Years of Plutonium Exposure to the Manhattan Project Plutonium Workers: An Update. Health Physics 73:611-619 (1997).
171. 2 in rats. Radiation Research 68:340-360 (1976).
172. 2 aerosol. I. Dosimetry. Health Physics 64:509-521 (1993).
173. 2 aerosol. III. Survival and lung tumors. Intern J Radiat Biol 64: 417-430 (1993).
174. Redpath JL, SC Short, M Woodcock, et al. Low-dose reduction in transformation frequency compared to unirradiated controls: The role of hyper-radiosensitivity to cell death. Radiat Res 159:433-436 (2003).
175. Scott BR. A biologically-based model that links genomic instability, bystander effects, and adaptive response. Mutat Res 568:129-143 (2004).
176. Scott BR, CL Sanders, REJ Mitchel and DR Boreham. CT scans may reduce rather than increase the risk of cancer. J Am Physicians and Surg 13:8-11 (2008).
177. Higson D. The Australasian Radiation Society's position statement on risks from low levels of ionizing radiation. Dose-Response 5:299-307 (2007).
178. Scott BR and J Di Palma. Sparsely ionizing diagnostic and natural background radiations are likely preventing cancer and other genomic-instability-associated diseases. Dose-Response 5:230-255 (2006).
179. Hickey RJ, EJ Bowers, DE Spence, et al. Low level ionizing radiation and human mortality: multi-regional epidemiological studies. Health Phys 40:625-641 (1981).
180. Scott BR. Low-dose-radiation stimulated natural chemical and biological protection against lung cancer. Dose-Response 6:299-318 (2008).
181. Neugut AI, E Robinson, WC Lee, et al. Lung cancer after radiation therapy for breast cancer. Cancer 71:3054-3057 (1993).
182. Vineis P, M Alavanja, P Buffler, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst 96:99-106 (2004).